ALESSIA FORNONI, MD, PHD
Osteopathic Medicine in Miami, FL
License number
Florida ME92745
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
1611 M851, Miami, FL 33136
Phone
(305) 243-4664
(305) 585-1111 (Fax)
(305) 243-9927 (Fax)
(305) 585-1111 (Fax)
(305) 243-9927 (Fax)
Personal information
See more information about ALESSIA FORNONI at radaris.comName
Address
Phone
1900 S Treasure Dr APT 8R, North Bay Village, FL 33141
7745 SW 54Th Ave, Miami, FL 33143
Miami, FL
1085 84Th St, Miami, FL 33138
1085 84Th St, Miami, FL 33138
Organization information
See more information about ALESSIA FORNONI at bizstanding.comAlessia Fornoni MD,PHD
1611 NW 12 Ave, Miami, FL 33136
Industry:
Hospitalist, Internist
Phone:
(305) 243-4664 (Phone)
Description:
There are 13 doctors at this site. Surgery is not performed at this site.
Alessia Fornoni
Professional information
Alessia Fornoni, Miami FL
Specialties:
Internal Medicine, Nephrology, Hospitalist
Work:
Veterans Affairs Medical Center - Miami
1201 NW 16Th St, Miami, FL 33125 Jackson Memorial Hospital
1500 NW 12Th Ave, Miami, FL 33136 Jackson Memorial Hospital
1611 NW 12Th Ave, Miami, FL 33136 Diabetes Research Institute
1450 NW 10Th Ave, Miami, FL 33136
1201 NW 16Th St, Miami, FL 33125 Jackson Memorial Hospital
1500 NW 12Th Ave, Miami, FL 33136 Jackson Memorial Hospital
1611 NW 12Th Ave, Miami, FL 33136 Diabetes Research Institute
1450 NW 10Th Ave, Miami, FL 33136
Education:
Universita Degli Studi Di Pavia (1995)
Alessia Fornoni, Miami FL
Specialties:
Internist
Address:
1120 Nw 14Th St, Miami, FL 33136
1500 Nw 12Th Ave, Miami, FL 33136
1500 Nw 12Th Ave, Miami, FL 33136
Education:
University of Pavia, Faculty of Medicine and Surgery - Doctor of Philosophy
University of Pavia, Faculty of Medicine and Surgery - Doctor of Medicine
Jackson Memorial Hospital - Fellowship - Nephrology (Internal Medicine)
University of Pavia, Faculty of Medicine and Surgery - Doctor of Medicine
Jackson Memorial Hospital - Fellowship - Nephrology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)
Dr. Alessia Fornoni - MD (Doctor of Medicine)
Hospitals:
University Of Miami-Nephrology
1475 NW 12Th Ave, Miami 33136
Kendall Regional Medical Center
11750 Bird Rd, Miami 33175
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
University of Miami Hospital
1400 West 12Th Ave, Miami 33136
University Of Miami-Nephrology
1475 NW 12Th Ave, Miami 33136
Kendall Regional Medical Center
11750 Bird Rd, Miami 33175
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
University of Miami Hospital
1400 West 12Th Ave, Miami 33136
1475 NW 12Th Ave, Miami 33136
Kendall Regional Medical Center
11750 Bird Rd, Miami 33175
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
University of Miami Hospital
1400 West 12Th Ave, Miami 33136
University Of Miami-Nephrology
1475 NW 12Th Ave, Miami 33136
Kendall Regional Medical Center
11750 Bird Rd, Miami 33175
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
University of Miami Hospital
1400 West 12Th Ave, Miami 33136
Education:
Medical Schools
Universita Degli Studi Di Pavia, Facolta Di Medicina E Chirurgia
Graduated: 1995
Universita Degli Studi Di Pavia, Facolta Di Medicina E Chirurgia
Graduated: 1995
Assays, Methods And Kits For Predicting Renal Disease And Personalized Treatment Strategies
US Patent:
2013020, Aug 8, 2013
Filed:
Oct 14, 2011
Appl. No.:
13/879892
Inventors:
Alessia Fornoni - Coral Gables FL, US
George William Burke - Miami FL, US
George William Burke - Miami FL, US
International Classification:
G01N 33/50, A61K 39/395, A61K 38/17, C12Q 1/68, A61K 31/724
US Classification:
4241341, 435 29, 435 613, 506 10, 506 15, 4352871, 514 58, 4241331
Abstract:
Assays, methods and kits for predicting a subject's (e.g., human) risk of primary glomerulopathy, secondary glomerulopathy or recurrence (e.g., post-transplant recurrence) of any glomerular disease include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Assays for predicting if a diabetic subject will develop kidney disease or a patient with FSGS will develop recurrent disease after transplant also include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Also described herein are compositions and methods for treating and preventing the afore-mentioned disorders.